Lloyd K Morgan
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- PO Box 150, Lorne, VIC 3232.
Correspondence: lloydmorgan@iprimus.com.au
- 1. O’Leary F, Hanson J, Bradbury R, Thanakrishman G. Fatal leptospirosis presenting as musculoskeletal chest pain. Med J Aust 2004; 180: 29-31. <MJA full text>
- 2. Guidugli F, Castro AA, Atallah AN. Antibiotics for leptospirosis (Cochrane review). In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.
- 3. Takfuji E, Kirkpatrick J, Miller R, et al. An efficiency trial of doxycyline chemoprophylaxis against leptospirosis. N Engl J Med 1984; 310: 497-500.
- 4. Kucers A, Crow S, Grayson M, Hoy J. The use of antibiotics: a clinical review of antibacterial, antifungal and antiviral drugs. 5th ed. Boston: Butterworth-Heinemann, 1997.
- 5. Friedland J, Warral D. The Jarisch-Herxheimer reaction in leptospirosis: possible pathogenesis and review. Rev Infect Dis 1991; 13: 207-210.
- 6. Katz A, Ansdell V, Effler P, et al. Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii 1974–1998. Clin Infect Dis 2001; 33: 1834-1841.
- 7. Therapeutic guidelines. Antibiotic. Version 12. Melbourne: Therapeutic Guidelines, 2003.
Online responses are no longer available. Please refer to our instructions for authors page for more information.